Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Sorrento Therapeutics Inc (SRNE)

OTC Markets
Currency in USD
Disclaimer
0.0200
0.0000(0.00%)
Closed
After Hours
0.02000.0000(0.00%)

SRNE Comments

It touched 1.15 :(
1.23?? whats happening!!!! why why why is this going down!
last time I invested to this stock at ~14$. Now, I am owner again. :)
waiting for it to get back to $14 again, that would be great!
 oh yes, 1,3 :)
1.35 sheesh!! 52 week low of 1.15 might be coming in, i really do not want to go bankrupt. Come on SRNE show some magic by christmas!
1.70 again, ouch!
jeez what a beating, is it never gonna end?
so took the 'a' out of the *****
they bleeped out the word 'rectl' cancer
Dostarlimab from the pharmaceutical company GlaxoSmithKline acheives 100% success in treating patients with *******cancer - 14 patients in one study show no form of *******cancer after the treatment. Wonder what our guys at SRNE are doing, other companies are getting their magic bullets. Good lord if any of you guys own GlaxoSmithKline, good on ya, thats going to get you set for the start of a good life. Hope SRNE jumps on the bandwagon soon enough.
I just bought another 1000 shares. research says its a bargain, value = 3.4 a share
Respect buddy, average it out.I would love to have my cost price at $1.60, but would need to buy 200,000 shares! haha
This compny will reverse split before you see 3 agian just sell.
You must be shorting the stock
Gents I've gotta level with you, as Crim Jamer mentioned on 18th April 2022, the possibility of SRNE going below $1 seems very much likely...If I had the cash I would definitely buy more and average but the fact is for this to come back to a solid $10 and above range is going to be a waiting period of at least 5 years..hoping the time period is less but things look really f88ked up, pretty much operators manipulating the stock to have us sell off and they can reap this really cheap and then enjoy selling it out at anywhere between $12 - $18, while we look on as twits. Those who can average they should, those who can't lets wait it out.
What are you??… a human crystal ball!?!?… 5 years???🤔… you think its gonna be 5 years before anything is approved??
This needs to have M&A !!!!!!!!!!!
really something else this company and if you notice they haven't promoted any news is like they want this stock to zinc to a dollar level
and now it has.... $1.15 reached:( cant even decide if this would be a buying opportunity and how long will we have to hold to get decent returns
almost $0.15
THIS IS SOMETHING WHERE THE WIN - WIN RATIO IS HOVERING AROUND 50 - 50.
SHORTS % 53 MILLION
Other large investors have also modified their holdings of the company. Arizona State Retirement System increased its stake in shares of Sorrento Therapeutics by 2.7% during the third quarter. Arizona State Retirement System now owns 74,376 shares of the biopharmaceutical company’s stock worth $567,000 after buying an additional 1,986 shares during the period. Crescent Grove Advisors LLC lifted its holdings in shares of Sorrento Therapeutics by 10.0% during the third quarter. Crescent Grove Advisors LLC now owns 22,000 shares of the biopharmaceutical company’s stock worth $168,000 after purchasing an additional 2,000 shares during the period. AE Wealth Management LLC lifted its holdings in shares of Sorrento Therapeutics by 17.0% during the third quarter. AE Wealth Management LLC now owns 14,661 shares of the biopharmaceutical company’s stock worth $112,000 after purchasing an additional 2,126 shares during the period. Newbridge Financial Services Group Inc. lifted its holdings in shar
wow thats a lot of pick up fo SRNE, so a boom is coming in soon, just need to see when.
hey be alert I have a feeling this next Monday will be at 5 levels lots of shorters closing on Friday so Monday we should moon hopefully brother
Lets see it looks like this company has the best pipe line and good news we just need to ready for a short squeeze on Thursday or Friday seen most contracts expired on Friday it should fly
Thats going to be the worst case scenario Crim, if it reaches 70 cents then uffff we're f*ked
Really hope it doesn't buddy!
i'm also holding the bag from 8 *****analyst price target was like $26 last february? LOL.
1.917 and going lower, thats it, yeesh! What a bummer!
Any News on BIG PHARMAS are looking for SORRENTO !!!
and there we go like always no wonder why Noone wants to buy is ridiculous this drop for what for have a excellent report plus a good pipeline come on
https://finance.yahoo.com/news/scilex-holding-company-majority-owned-130000315.html
Is there are any NEWS on BuyBack or M&A !!!!The price from $19 till date needs to get some Boost !!!!!!
The Trend from here end is looking BULLISH !!!!
yes we have 2 resistance at 2.45 and at 2.75 if we brake it and we could be at 2.80s for more than 30 minutes than is show time we should see 3s level b4 closing if everything is good
What is the Call ????
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.